Medtronic (MDT): FY26 Q3 earnings call, Feb 17, 2026
No Kalshi or Polymarket word markets were listed for Medtronic’s Feb 17, 2026 earnings call (FY26 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
4 matches for “MiniMed”; 3 quoted, at least 25 words apart.
…so swiftly after the U.S. launch. Wrapping up our business performance is MiniMed, our Diabetes business, which delivered 15% reported and over 8% organic growth.…
…the majority of commercially insured lives in the U.S. And we submitted MiniMed Flex to the U.S. FDA and began the U.S. pivotal study for…
…it to the U.S. FDA by this fall. The planned separation of MiniMed is perfectly on track. Our preferred path continues to be a two-step,…
Agents: this page as TSV at /api/v1/appearances/medtronic:2026-02-17:earnings_call · words: /api/v1/brief?appearance=medtronic:2026-02-17:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP